Journal Home
Search for

Volume 89, Issue 1, Pages 10-15 (January 2008)


View previous. 7 of 41 View next.

Team Training and Stroke Rehabilitation Outcomes: A Cluster Randomized Trial

Dale C. Strasser, MDaCorresponding Author Informationemail address, Judith A. Falconer, PhDb, Alan B. Stevens, PhDc, Jay M. Uomoto, PhDd, Jeph Herrin, PhDef, Susan E. Bowen, PhDg, Andrea B. Burridge, PhDh

Abstract 

Strasser DC, Falconer JA, Stevens AB, Uomoto JM, Herrin J, Bowen SE, Burridge AB. Team training and stroke rehabilitation outcomes: a cluster randomized trial.

Objective

To test whether a team training intervention in stroke rehabilitation is associated with improved patient outcomes.

Design

A cluster randomized trial of 31 rehabilitation units comparing stroke outcomes between intervention and control groups.

Setting

Thirty-one Veterans Affairs medical centers.

Participants

A total of 237 clinical staff on 16 control teams and 227 staff on 15 intervention teams. Stroke patients (N=487) treated by these teams before and after the intervention.

Intervention

The intervention consisted of a multiphase, staff training program delivered over 6 months, including: an off-site workshop emphasizing team dynamics, problem solving, and the use of performance feedback data; and action plans for process improvement; and telephone and videoconference consultations. Control and intervention teams received site-specific team performance profiles with recommendations to use this information to modify team process.

Main Outcome Measures

Three patient outcomes: functional improvement as measured by the change in motor items of the FIM instrument, community discharge, and length of stay (LOS).

Results

For both the primary (stroke only) and secondary analyses (all patients), there was a significant difference in improvement of functional outcome between the 2 groups, with the percentage of stroke patients gaining more than a median FIM gain of 23 points increasing significantly more in the intervention group (difference in increase, 13.6%; P=.032). There was no significant difference in LOS or rates of community discharge.

Conclusions

Stroke patients treated by staff who participated in a team training program were more likely to make functional gains than those treated by staff receiving information only. Team based clinicians are encouraged to examine their own team. (ClinicalTrials.gov identifier NCT00237757).

Article Outline

Abstract

Methods

Participants

Interventions

Outcomes

Case-Mix Severity

Randomization

Sample Size

Statistical Analysis

Results

Discussion

Conclusions

Acknowledgment

References

Copyright

IN INCREASINGLY COMPLEX medical environments and across a spectrum of medical conditions, effective health service coordination has become a crucial component of quality of patient care. Delivery of care by organized, coordinated, patient care teams represent a logical response to this challenge. People with complex disabilities are best managed by an interdisciplinary group of professionals with complementary skills to address the biopsychosocial determinants of functions. Teams enable practitioners to coordinate services across medical specialties and with diverse health professionals.

The role of the interdisciplinary team in rehabilitation is widely endorsed. Medicare requires interdisciplinary, team care for inpatient, rehabilitation reimbursement.1 The Committee on Accreditation of Rehabilitation Facilities (CARF) regards team care as an indicator of provider quality.2 In the Institute of Medicine report, Crossing the Quality Chasm,3, 4 effective teams featured prominently as a means to improve quality of care. Observational studies show the value of a team approach for chronic disease management5, 6, 7 and in acute hospital settings8, 9 and recent clinical trials provide evidence for enhanced patient outcomes when care is delivered by a patient team compared with a nonteam.10, 11, 12, 13

Throughout the last decade, the Veterans Affairs (VA) Rehabilitation Teams Project has examined the relationship between interdisciplinary rehabilitation team functioning and patient outcomes. Initially, we developed a model and measures of team process consisting of 4 central components: leadership, interdisciplinary relations, social climate, and managerial practices.14, 15, 16, 17 In a subsequent observational study of 46 VA hospitals, 530 staff, and 1688 patients, we found that selected characteristics of the rehabilitation team process predicted superior patient outcomes.18 We also found that the critical variables varied, depending on the outcome of interest. Based on the team functioning model and the findings from the observational study, we developed a training program to improve patient outcomes through enhanced team functioning. In this training program, clinical rehabilitation staff were taught skills to improve team effectiveness and provided with consultation services to enact an action plan based on their self-analysis.

In this article, we report the results of a randomized controlled trial conducted to evaluate the effects of this rehabilitation team training program on stroke patient outcomes.

Methods 

return to Article Outline

This was a cluster randomized trial in which the rehabilitation team managing stroke patients at each of 31 VA hospitals in the United States were randomized to receive either information and training (intervention) or information only (control) on effective team functioning. We collected data on 3 patient outcomes—change in functional status from admission to discharge, length of stay (LOS), and discharge disposition—from each site for all admissions during 12 months preintervention and 12 months postintervention, with an intervening 6 months allowed for the intervention. We then compared changes in patient outcomes between the intervention and control groups to assess the effectiveness of the intervention.

Participants 

All VA hospitals with active inpatient (acute or subacute) rehabilitation units that treated a minimum of 2 stroke patients per month and that subscribe to the VA Functional Status Outcomes Database (FSOD)19 were eligible for and recruited for inclusion in the trial. The FSOD uses the FIM instrument and classifies function on a scale of 1 (total dependence) to 7 (independence) on each of 18 items; 13 of these items are related to motor function, and 5 are related to cognitive function.20, 21 The FIM has been shown to show good reliability and validity21 and it has been used extensively22, 23 to assess patient outcomes. All teams had representatives from 6 professional disciplines—medicine, nursing, occupational therapy (OT), speech-language pathology (SLP), physical therapy (PT), and case management/social work. Patients were included if their demographic and assessment data were reported to the FSOD by one of the participating units, with discharge date within either the baseline or follow-up assessment period for that site. Patients were excluded if they had invalid or missing FIM assessments; fewer than 2 FIM assessments; or LOS of 3 days or less. Primary analyses were limited to patients with a diagnosis of stroke, and time since onset of 90 days or less. Additional analyses were conducted on all patient data, regardless of primary diagnosis. Each study site obtained approval from the local VA research committees and affiliated institutional review boards (IRBs).

Interventions 

The 6-month team training intervention occurred in 3 phases and involved 227 rehabilitation staff. It began with a concentrated 2.5-day team training workshop designed for 2 self-identified team leaders from each of the 15 experimental sites. Rehabilitation medicine (13 physicians or osteopaths) was the most commonly represented discipline among the team leaders. Other participating leaders included nursing (2 registered nurses), PT (4 therapists), OT (2 therapists), kinesiotherapy (3 kinesiologists), social work (1 social worker/case manager), SLP (3 speech-language pathologists), and 2 administrators. The workshop emphasized skill development in team problem-solving strategies and the use of program evaluation data. The second phase occurred 3 to 5 weeks after the workshop and consisted of written action plans to address team process problems based on discussions at the earlier workshop. In the third phase (months 3 to 6), workshop participants received telephone and videoconference consultation (eg, advice on implementation of action plans, facilitation of team process skills).

Treatment implementation, a research methodology commonly used in psychosocial interventions, guided the design and implementation of our team training intervention. Using the framework of Lichstein et al,24 3 categories of treatment implementation were used and monitored: delivery, receipt, and enactment. Treatment implementation methods helped to ensure consistent and reliable delivery of the intervention by research staff and to document skill use by participants. A complete description of the treatment implementation methods used in this study along with specific content and evidence for the integrity and fidelity of the team training intervention is presented elsewhere.25

Individual team leaders in both the team training and information only groups received summaries of their own team’s performance on process measures taken preintervention and again at the end of the intervention. These summaries included comparison data collected from the larger sample and again after the completion of the intervention. The summary documents also contained suggestions on how to use these data and options for individual consultations with project staff. Financial resources ($1000 per site) were provided to offset expenses incurred during the study. Suggestions were offered on how the team process reports and funds could be used to promote effective team functioning. These activities defined the standard feedback condition.

The inpatient services use a multidisciplinary team approach to evaluate and treat rehabilitation patients. This is the standard of care and consistent with guidelines of the Center for Medicare & Medicaid Services of the U.S. Department of Health and Human Services1 and CARF.2 Core disciplines represented on the team generally include medicine, nursing, PT, OT, SLP, and social work or case management.

Outcomes 

The primary outcome of this trial was the change from admission to discharge in the motor skills component of the FIM score. Secondary outcomes were LOS (measured in days) and discharge disposition (discharged to home or discharged to other location).

Outcome data on discharged patients were collected from the VA FSOD. In addition, we collected patient demographic (age, sex, race and ethnicity, marital status), clinical (diagnostic class), and treatment (admission class, program interruption) characteristics. FIM assessments were done by clinical staff at each facility in the standard manner and consistent with published guidelines of the Unified Data Systems.26 Staff from each site performed FIM assessments and participated in the VA FSOD for a minimum of 5 years prior to this study.

For each participating site, we collected data on all patients admitted during the 12-month period prior to the intervention (preintervention) and during the 12-month period after the completion of the intervention (postintervention). Because of the nature of the intervention, these periods were staggered across participating sites.

Case-Mix Severity 

To account for differences in admitting motor FIM score across study groups, all comparisons of outcomes were adjusted for functional-related groups (FRG) category. FRGs account for case mix severity27, 28 by assigning patients to 1 of 9 categories according to admission motor FIM score and age; the first (lowest severity) category was used as a reference category in models.

Randomization 

We stratified the 31 participating sites into 4 groups according to volume of patients (above or below median) and average admission FIM of stroke patients (above or below median); volume and FIM scores were based on stroke patients discharged for the year leading up to September 2000. Within each stratum we randomized sites to either intervention or control group using a computer; each stratum was force randomized to have 4 sites in 1 arm.

Sample Size 

Because the patients were clustered within study sites, we calculated our statistical power using methods appropriate for cluster-randomized outcomes.29 Using data from 45 VA rehabilitation sites which participated in a previous observational study18 we estimated the intracluster correlation in motor FIM score gain to be 4.6% and the standard deviation (SD) to be 12.8; assuming at least 20 patients per site, we anticipated that with 28 sites we would have 80% power to detect a difference in motor FIM gain between study arms of 6 points.

Statistical Analysis 

We used analytic techniques appropriate for cluster-randomized trials.30, 31 First, we summarized patient characteristics by study arm and overall, and tested for differences between the 2 arms using cluster-adjusted chi-square and t tests.30

When we assessed change in motor FIM scores for normality we identified anomalies indicating that these scores were potentially biased upward for patients with negative gain. That is, the number of patients with gain exactly equal to zero was much higher, and the number of patients with negative gain much lower, than expected by chance, and moreover, the rate of zero gains was twice as high in the control group as in the intervention group (P<.001). This is the pattern one would expect if patients with negative gain (ie, discharge FIM score lower than admission FIM score) were being reported as zero gain. Thus, to avoid potential bias toward the null caused by upward rounding of the outcome, we dichotomized motor FIM gain for each patient as either above or below the overall median of 23 points gained. This dichotomized outcome was used for all analyses of the primary outcome.

To assess the effect of the intervention on the 3 patient outcomes we used hierarchical generalized linear models. Such models are appropriate when comparing outcome measures that have been randomized in clusters,30, 31 and allowed us to adjust for patient characteristics that were imbalanced across study arms. For each outcome we estimated either a logistic (motor FIM gain above median and discharge disposition) or linear (LOS, log transformed to reduce skewness) hierarchical generalized linear model, with each outcome measure assumed to vary both within and across study sites. Each model included an indicator variable for study condition (intervention vs control), and indicator variable for measurement period (preintervention or postintervention), and an indicator representing the interaction between these 2. By testing the hypothesis that the interaction term was different from zero, we were able to test whether the intervention had an effect on team performance as measured by each patient outcome. For example, to test the hypothesis that the intervention increased the probability of patients gaining more than 23 points, we estimated the following model: Let Yij indicate wither the ith patient at the jth site had a gain of at least 23 points on motor FIM; let P indicate whether that patient was admitted pre- (P=0) or post- (P=1) intervention, and let E indicate whether that patient was treated at a control (E=0) or intervention (E=1) study site. Then we estimated:

where βFRG*FRG is a vector representing admission FRG and νj∼N(0,σu2) represents an error term at the site level. By testing H0T=0 we can test whether the intervention has an effect on the patient outcome.

The primary analysis included only stroke patients with time since onset of 90 days or less. We replicated the analysis using all patients discharged during the data collection periods.

Results 

return to Article Outline

Of 33 eligible sites, a total of 31 sites agreed to participate, initiated the IRB approval, and were randomized (fig 1). One control site was unable to complete the IRB process and withdrew, and 1 intervention site did not report data to the FSOD, leaving 15 sites in the control group and 14 in the intervention group. Of the 29 that contributed patient data to the FSOD during the preintervention period, 27 also contributed patient data to the FSOD for the postintervention period (table 1). These 29 sites discharged a total of 7907 patients during the 2 study periods; after exclusions for FIM errors (n=70), fewer than 2 assessments (n=33), and LOS of less than 4 days (n=134), 7670 patients remained. Of these, 1368 were stroke patients with time since onset of 90 days or less. There were no differences between study conditions in demographic characteristics (table 2). Control sites admitted stroke patients with lower initial (admission) motor FIM scores during the preintervention periods (P=.002); thus, we adjusted all analyses using FRGs (see above), a classification based on initial motor FIM and age.


View full-size image.

Fig 1. CONSORT flowchart.


Table 1.

Characteristics of 29 Sites Included in Study

CharacteristicsControlIntervention
No. of sites1514
Preintervention
No. of patients123(73−373)143(20−373)
No. of stroke patients23(13−76)21(3−75)
Average admission motor FIM52.2±3.952.4±3.8
Average time since onset(d)22(8−45)18(12−38)
Postintervention
No. of patients141(5−367)100(3−379)
No. of stroke patients22(1−79)16(0−48)
Average admission motor FIM50.5±5.553.3±6.0
Average time since onset(d)30(9−99)16(6−106)

NOTE. Values are median (range) or mean ± SD.

For time since onset less than 1 year.

Table 2.

Characteristics of 1374 Stroke Patients With Time Since Onset of 90 Days or Less From 28 Sites Included in Analysis

CharacteristicsPreinterventionPostintervention
ControlInterventionDifferenceControlInterventionDifference
N439350 346233
Demographics
Age (y)66.6±12.065.9±11.4>.10066.9±11.967.6±11.1>.100
Sex >.100 >.100
Male96.8(425)98.3(344) 97.4(337)96.6(225)
Female3.2(14)1.7(6) 2.6(9)3.0(7)
Unknown0(0)0(0) 0.0(0)0.4(1)
Ethnicity >.100 >.100
White55.6(244)57.7(202) 53.8(186)62.7(146)
Black24.6(108)30.9(108) 24.6(85)22.7(53)
Hispanic17.1(75)8.9(31) 19.9(69)9.4(22)
Asian1.1(5)0.6(2) 0.6(2)0.9(2)
Native American1.1(5)0.6(2) 0.3(1)0.9(2)
Other0.2(1)0.9(3) 0.9(3)3.0(7)
Unknown0.2(1)0.6(2) 0.0(0)0.4(1)
Marital status >.100 >.100
Married51.5(226)41.4(145) 49.1(170)42.1(98)
Divorced23.0(101)25.4(89) 25.1(87)27.9(65)
Never married9.3(41)14.3(50) 10.1(35)9.0(21)
Widowed10.7(47)11.7(41) 11.8(41)13.3(31)
Separated4.1(18)4.9(17) 3.8(13)7.3(17)
Unknown1.4(6)2.3(8) 0.0(0)0.4(1)
Clinical
Initial motor FIM43.5±16.948.2±17.9.00246.2±18.949.9±16.9.092
Initial total FIM66.6±21.871.6±22.8.00770.0±24.174.5±21.5.119

NOTE. Values are mean ± SD or percentage (n).

Results of both the primary (stroke only) and secondary analyses (all patients) are shown in Table 3, Table 4. There was a significant difference in improvement in motor FIM score between the intervention groups (13.6% absolute difference in percentage of patients gaining more than 23 points, P=.038). There was no significant difference for the other 2 outcome measures (P>0.1 for both). In the analysis including all patients, there was a smaller but still significantly greater improvement in motor FIM scores in the intervention group than in the control group (6.1%, P=.029), with no corresponding intervention effect on the other 2 outcomes.

Table 3.

Results of Comparisons Between Intervention Arms in Change From Pre- to Postintervention Period

OutcomeControlInterventionDifference of DifferencesP
PrePostPrePost
Stroke patients only
N439346350233
Motor FIM gain >23 (%)47.438.242.947.213.6.032
LOS (d)23.820.519.919.63.0.180
Sent home (%)74.372.876.680.75.5.257
All patients
N2120164823371565
Motor FIM gain >23 (%)47.543.449.351.36.1.029
LOS (d)18.817.616.014.8−0.1.980
Sent home (%)82.982.683.286.23.3.214
Table 4.

Results of Models to Test Effect of Intervention on 3 Outcomes

EffectFIM Gain ≥23LOS (log)Sent Home
Coeff ± SEPCoeff ± SEPCoeff ± SEP
Intercept−0.416±0.145.0083.009±0.057.0001.083±0.165.000
Exposure0.005±0.202.982−0.135±0.084.1180.037±0.244.880
FRG
21.484±0.436.0010.480±0.083.000−2.108±0.377.000
33.071±0.373.0000.539±0.067.000−0.147±0.309.634
42.709±0.328.0000.450±0.054.000−0.165±0.254.515
51.504±0.347.0000.025±0.060.6760.404±0.300.178
61.901±0.368.0000.335±0.067.000−0.421±0.308.172
72.200±0.337.0000.210±0.057.0000.070±0.277.801
8−0.982±0.519.058−0.125±0.063.0451.109±0.369.003
Post
Intercept−0.285±0.169.092−0.131±0.039.001−0.015±0.182.934
Exposure0.547±0.263.0380.080±0.060.1800.329±0.290.257

Abbreviations: Coeff, coefficient; SE, standard error.

Because 2 control sites did not report postintervention data, we replicated the analysis using only the 27 sites that reported both pre- and postintervention patient data. Because these 2 control sites reported only a total of 38 patients during the preintervention period, there was negligible difference in the results, with effect of the intervention on motor FIM improvement still significant (P=.038).

Discussion 

return to Article Outline

In this cluster randomized trial, an intervention designed to improve the effectiveness of interdisciplinary stroke rehabilitation teams was associated with an important and statistically significant improvement in patient motor function, as measured by the proportion of stroke patients gaining more than 23 points on their motor FIM during treatment. The proportion of stroke patients making greater than the medium functional gain increased by 4.4% in the intervention group, whereas it decreased by 9.2% in the control group, lending further support to the effect of the intervention. At the same time, the intervention had no measurable effect on LOS or on discharge destination.

Though a randomized trial is subject to less systematic bias than other study designs, there are some limitations to consider when assessing validity and generalization of these results. First, despite randomizing within strata determined by initial FIM scores during the year prior to the study, the randomization resulted in control sites having a greater volume of stroke patients and a lower initial functional status than the experimental sites. Higher patient volume within a specific diagnosis may lead to specialization of treatment and improved outcomes, but a lower initial functional status creates a greater range for improvement. Thus, these factors would tend to bias the data toward the null (no effect of intervention). Moreover, we adjusted analyses for FRGs to account for this difference. Second, although the participating teams and patients are representative of the VA health system, the VA health system is not representative of the U.S. stroke population; the patient sample was predominantly male and represented a lower socioeconomic class than found in the general population. Third, during the study period, the Veterans Health Administration experienced major changes in organizational processes and resource allocations,32 including a significant decrease in inpatient rehabilitation services; it is not clear how these changes might have biased the results, but they do indicate some caution in interpretation.

Although it is possible, we doubt that an attention placebo can explain sustained improvements in patient outcomes. Periodically, hospital staff receives special attention from the organization, frequently in relation to accreditation requirements, governmental regulations, and/or financial concerns. In our experience benefits from these efforts are usually short-lived because they have been initiated without an understanding of team process.

We propose that our intervention taught the necessary skills and provided a useful conceptual model to positively impact on the team dynamics. Teams are willing and able to modify their practices to the extent that they perceive that change will benefit themselves and their patients. By temperament, however, they tend to be practical and task-oriented. Their work loads are heavy. The patients are challenging. Rarely, if ever, do we hear of teams that are satisfied with the resources and support they receive. In the bustle of an ordinary day, the many insightful observations made by clinicians to enhance team process are less likely to find their way into an ongoing plan of action. Heightened attention and incentives to evaluate team process may have served as a catalyst that was necessary, but insufficient, to stimulate meaningful, sustainable improvements in patient outcomes.

The training workshops provided a sequestered forum for team leaders to think about the team and their role on the team, to learn practical skills for building-team strengths, and to develop site-specific action plans based on agreed-on, priority areas of need. Within the workshop, the model of team functioning helped to organize, broaden and elevate the discussions. The workshop leaders provided direction, content information, and customized feedback on performance, but it was the team members themselves, through their own efforts and resources, that enacted change in the patient outcomes.

The team process—how the team goes about coordinating and communicating its work, and the attitudes and perceptions expressed by its members—exerts a meaningful effect on patient outcomes. Team-based clinicians interested in improving patient outcomes are encouraged to examine their team structure and process. To this end, we offer as a starting point: a conceptualization of the components of teams in terms of leadership, managerial practices, social climate, and interprofessional relations14, 15; measures to characterize and profile one’s team functioning strengths16, 17, 18, 33 and identify target areas for intervention and improvement; and a training program grounded in principles of problem-solving and information feedback.25

Conclusions 

return to Article Outline

Stroke patients treated by rehabilitation staff who participated in a team training program were more likely to make functional gains than those patients treated by staff receiving only information. Findings from this clinical trial further our understanding of the relationship between patient outcomes and team process variables. Practitioners in all health care services that work in teams, or who are looking toward the development of teams, are encouraged to examine how team functioning affects patient outcomes and to develop interventions to optimize treatment effectiveness.

Acknowledgments 

return to Article Outline

We thank the staff at the participating hospitals (listed below), and we gratefully acknowledge the assistance of the Veterans Administration Physical Medicine and Rehabilitation Service Central Office, and the Corporate Franchise Data Center, Austin, TX.

The participating hospitals include: New Mexico VA Health Care System (Albuquerque, NM), Charles Norwood VA Medical Center (Augusta, GA), Bay Pines VA Healthcare System (Bay Pines, FL), Jesse Brown VA Medical Center (Chicago, IL), Louis Stokes VA Medical Center (Cleveland, OH), Dayton VA Medical Center (Dayton, OH), VA Eastern Colorado Health Care System (Denver, CO), Edward Hines Jr. VA Hospital (Chicago, IL), Michael E. DeBakey VA Medical Center (Houston, TX), Richard L. Roudenbush VA Medical Center (Indianapolis, IN), Lexington VA Medical Center (Lexington, KY), John L McClellan Memorial Veterans Hospital (Little Rock, AR), VA Loma Linda Healthcare System (Loma Linda, CA), VA Greater Los Angeles Healthcare System (Los Angeles, CA), Miami VA Healthcare System (Miami, FL), Clement J. Zablocki VA Medical Center (Milwaukee, WI), Minneapolis VA Medical Center (Minneapolis, MN), VA New York Harbor Healthcare System (New York, NY), Oklahoma City VA Medical Center (Oklahoma City, OK), VA Palo Alto Healthcare System (Palo Alto, CA), Portland VA Medical Center (Portland, OR), Hunter H. McGuire VA (Richmond, VA), VA Caribbean Healthcare System (San Juan, Puerto Rico), St Louis VA Medical Center (St. Louis, MO), Syracuse VA Medical Center (Syracuse, NY), James A. Haley Veterans’ Hospital (Tampa, FL), Northern Arizona Health Care System (Tucson, AZ), Washington, DC VA Medical Center (Washington, DC), and VA Boston Healthcare System (West Roxbury Campus, Boston, MA).

References 

return to Article Outline

1. 1Centers for Medicare & Medicaid Services. Documentation requirements for inpatient rehabilitation (A18990). http://www.wvtra.org/conference/2006/Veritus_IRF.docAccessed September 22, 2007.

2. 2Commission on Accreditation of Rehabilitation Facilities. Medical rehabilitation standards manual. Tucson: CARF; 2005;.

3. 3Institute of Medicine. Crossing the quality chasm. In: Washington (DC): Natl Acad Pr; 2001;p. 337.

4. 4Fernandopulle R, Ferris T, Epstein A, et al. A research agenda for bridging the “quality chasm”. Health Aff (Millwood). 2003;22:178–190. MEDLINE | CrossRef

5. 5Von Korff M, Gruman J, Schaefer J, Curry SJ, Wagner EH. Collaborative management of chronic illness: essential elements. Ann Intern Med. 1997;127:1097–1102. MEDLINE

6. 6Boult C, Kane RL, Pacala JT, Wagner EH. Innovative healthcare for chronically ill older persons: results of a national survey. Am J Manag Care. 1999;5:1162–1172. MEDLINE

7. 7Rich MW, Beckham V, Wittenberg C, Leven CL, Freedland KE, Carney RM. A multidisciplinary intervention to prevent the readmission of elderly patients with congestive heart failure. N Engl J Med. 1995;333:1190–1195. MEDLINE | CrossRef

8. 8Young GJ, Charns MP, Desai K, et al. Patterns of coordination and clinical outcomes: a study of surgical services. Health Serv Res. 1998;33(5 Pt 1):1211–1236. MEDLINE

9. 9Shortell SM, Zimmerman JE, Rousseau DM, et al. The performance of intensive care units: does good management make a difference?. Med Care. 1994;32:508–525. MEDLINE | CrossRef

10. 10Langhorne P, Dennis MS. Stroke units: the next 10 years. Lancet. 2004;363:834–835. Full Text | Full-Text PDF (55 KB) | CrossRef

11. 11Callahan CM, Boustani MA, Unverzagt FW, et al. Effectiveness of collaborative care for older adults with Alzheimer disease in primary care: a randomized controlled trial. JAMA. 2006;295:2148–2157. CrossRef

12. 12Rummans TA, Clark MM, Sloan JA, et al. Impacting quality of life for patients with advanced cancer with a structured multidisciplinary intervention: a randomized controlled trial. J Clin Oncol. 2006;24:635–642. CrossRef

13. 13Walders N, Kercsmar C, Schluchter M, Redline S, Kirchner HL, Drotar D. An interdisciplinary intervention for undertreated pediatric asthma. Chest. 2006;129:292–299. MEDLINE | CrossRef

14. 14Strasser DC, Falconer JA. Linking treatment to outcomes through teams: building a conceptual model of rehabilitation effectiveness. Top Stroke Rehabil. 1997;4(1):15–27. CrossRef

15. 15Strasser DC, Falconer JA. Rehabilitation team process. Top Stroke Rehabil. 1997;4(2):34–39. CrossRef

16. 16Strasser DC, Smits SJ, Falconer JA, Herrin JS, Bowen SE. The influence of hospital culture on rehabilitation team functioning in VA hospitals. J Rehabil Res Dev. 2002;39:115–125. MEDLINE

17. 17Smits SJ, Falconer JA, Herrin J, Bowen SE, Strasser DC. Patient-focused rehabilitation team cohesiveness in Veterans Administration hospitals. Arch Phys Med Rehabil. 2003;84:1332–1338. Abstract | Full Text | Full-Text PDF (77 KB) | CrossRef

18. 18Strasser DC, Falconer JA, Herrin JS, Bowen SE, Stevens AB, Uomoto J. Team functioning and patient outcomes in stroke rehabilitation. Arch Phys Med Rehabil. 2005;86:403–409. Abstract | Full Text | Full-Text PDF (113 KB) | CrossRef

19. 19Reker DM, Reid K, Duncan PW, et al. Development of an integrated stroke outcomes database within Veterans Health Administration. J Rehabil Res Dev. 2005;42:77–92. MEDLINE | CrossRef

20. 20Hamilton BB, Granger CV, Sherwin FS, Zielezny M, Tashman JS. A uniform national data system for medical rehabilitation. In:  Fuhrer MJ editors. Rehabilitation outcomes: analysis and measurement. Baltimore: Brookes; 1987;p. 137–147.

21. 21Granger CV, Fiedler RC. The measurement of disability. In:  Fuhrer MJ editors. Assessing medical rehabilitation practices: the promise of outcomes research. Baltimore: Brookes; 1997;p. 103–126.

22. 22Sebastia E, Duarte E, Boza R, et al. Cross-validation of a model for predicting functional status and length of stay in patients with stroke. J Rehabil Med. 2006;38:204–206. MEDLINE | CrossRef

23. 23Hinkle J. Variables explaining functional recovery following motor stroke. J Neurosci Nurs. 2006;38:6–12. MEDLINE

24. 24Lichstein KL, Riedel BW, Grieve R. Fair tests of clinical trials: a treatment implementation model. Adv Behav Res Ther. 1994;16:1–29.

25. 25Stevens AR, Strasser DC, Uomoto J, Bowen SE, Falconer JA. Utility of treatment implementation methods in a clinical trial with rehabilitation teams. J Rehabil Res Dev. 2007;44:537–546. CrossRef

26. 26Uniform Data System for Medical Rehabilitation. Guide for the Uniform Data System for Medical Rehabilitation. New York: UB Foundation Activities; 1996;.

27. 27Stineman MG, Jette A, Fiedler R, et al. Impairment-specific dimensions within the Functional Independence Measure. Arch Phys Med Rehabil. 1997;78:636–643. Abstract | Full-Text PDF (723 KB) | CrossRef

28. 28Stineman MG, Granger CV. Outcome, efficiency, and time-trend pattern analysis for stroke rehabilitation. Am J Phys Med Rehabil. 1998;77:193–201. MEDLINE | CrossRef

29. 29Donner A, Klar N. Cluster-randomization trials in health research. London: Arnold; 2000;.

30. 30Murray D. Design and analysis of group-randomized trials. Oxford: Oxford Univ Pr; 1998;.

31. 31Omar R, Thompson S. Analysis of a cluster randomized trial with binary outcome data using a multi-level model. Stat Med. 2000;19:2675–2688. MEDLINE | CrossRef

32. 32Kizer KM. Health care, not hospitals: transforming the Veterans’ Health Administration. Washington (DC): U.S. Department of Veterans Affairs; 1998;.

33. 33Strasser D, Burridge A, Herrin JS, et al. Measuring team functioning to enhance patient outcomes. Poster presented to: Health Services Research and Development National Meeting; 2005 Feb 16-18; Baltimore (MD). Poster no. 3091.

a Department of Rehabilitation Medicine, Emory University, and Atlanta VA Medical Center, Atlanta, GA

b Northwestern University, Feinberg School of Medicine, Chicago, IL

c Scott & White Memorial Hospital, Texas A&M University System Health Science Center, Temple, TX

d Center for Polytrauma Care, VA Puget Sound Health Care System (Seattle Division), Seattle, WA

e Yale University, New Haven, CT

f Flying Buttress Associates, Charlottesville, VA

g TREP – HSR&D, Atlanta VA Medical Center, Decatur, GA

h Department of Educational Psychology, University of Houston, Houston, TX.

Corresponding Author InformationReprint requests to Dale C. Strasser, MD, 1441 Clifton Rd NE, Atlanta, GA 30322

 Supported by the Veterans Administration Rehabilitation Research and Development Service (Merit Review Grants B2367R, O3225R).

No commercial party having a direct financial interest in the results of the research supporting this article has or will confer a benefit upon the author(s) or upon any organization with which the author(s) is/are associated.

PII: S0003-9993(07)01606-1

doi:10.1016/j.apmr.2007.08.127


View previous. 7 of 41 View next.